A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that demonstrated a 96% reduction in infection risk. The prestigious journal ...

The women who use injectable drugs in Tunisia number in the thousands. Victims of violence, they turn to sex work where they are exposed to HIV infection. And yet they are ignored, rendered invisible ...

The study of 24,000 users found PrEP to be highly effective in a real-world setting A drug which stops HIV infecting the body has proved to be a highly effective "real-world" preventative ...

Lenacapavir, a first-in-class capsid inhibitor, is notable for its ability to inhibit HIV at multiple stages of its lifecycle. The drug has already been green-lit in multiple countries for the ...

What challenges do regions such as Africa and Latin America face around access to HIV medicines? We have recently seen impressive results from the Purpose 1 and 2 studies, which evaluated the efficacy ...

Rather than dying of AIDS, they could live with HIV. And access to those life-saving drugs became more accessible to people throughout the world when then-President George W. Bush initiated PEPFAR.

Lenacapavir has shown high efficacy in managing multidrug-resistant cases, offering hope to patients with limited alternatives. A significant breakthrough in treating the Human Immunodeficiency ...

Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...

In a new study, people living with HIV who got standard meds to keep the virus at bay also had much lower rates of Alzheimer's disease-- suggesting the drugs might also lower risks for the brain ...